Stran & Company (SWAGW) Financials
Newest figures come from the 10-Q for Q2 FY2026, filed Aug 11, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SWAGW SEC filings page.
Stran & Company (SWAGW) reported $119.5M in revenue over the twelve months to Jun 30, 2026, up 10.3% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Revenue expansion is being absorbed by rising overhead, leaving scale without dependable conversion into operating profit.
FY2025 revenue reached$116.2M while gross margin was29.5% , showing that added volume did not materially change the gross-profit economics. Cash conversion reversed: FY2024 produced positive operating cash flow despite a larger net loss, while FY2025's smaller net loss coincided with negative operating cash flow; earnings therefore do not yet provide a dependable cash proxy.
Gross margin peaked at
Total liabilities fell from
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Stran & Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Stran & Company held $11.6M in cash, cash equivalents and investments at the end of fiscal year 2025, and its operations used $4.7M of cash that year. Cash Runway ranks emerging companies on the size of that balance against the outflow behind it, and Stran & Company scores 55/100 among other emerging companies.
Stran & Company had 19M shares outstanding at the end of fiscal year 2025, against 19M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Stran & Company scores 72/100 among other emerging companies.
Not available for Stran & Company, and counted as zero in the overall score.
Stran & Company reported revenue of $116.2M in fiscal year 2025, against $82.7M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Stran & Company scores 67/100 among other emerging companies.
Stran & Company's operations used $4.7M of cash in fiscal year 2025, against $2.8M generated in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Stran & Company scores 20/100 among other emerging companies.
Stran & Company's cash, cash equivalents and investments came to $11.6M at the end of fiscal year 2025, against $18.8M of total liabilities. Balance Sheet ranks emerging companies on that comparison, and Stran & Company scores 47/100 among other emerging companies.
Stran & Company passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
Stran & Company reported a net loss of $747K while operations used $4.7M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Key Financial Metrics
Earnings & Revenue
Stran & Company generated $33.4M in revenue in Q2 2026. This represents an increase of 2.4% from the same quarter a year earlier. Against the prior quarter it is up 6.7%.
Stran & Company's EBITDA was $376K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 41.6% from the same quarter a year earlier. Against the prior quarter it is down 60.0%.
Stran & Company reported $309K in net income in Q2 2026. This represents a decrease of 51.9% from the same quarter a year earlier. Against the prior quarter it is down 58.5%.
Stran & Company earned $0.02 per diluted share (EPS) in Q2 2026. This represents a decrease of 33.3% from the same quarter a year earlier. Against the prior quarter it is down 50.0%.
Cash & Balance Sheet
Stran & Company generated $358K in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 94.4% from the same quarter a year earlier. Against the prior quarter it is down 69.6%.
Stran & Company held $7.4M in cash as of Q2 2026; long-term debt is not reported for that period.
Not reported for Q2 2026.
Margins & Returns
Stran & Company's gross margin was 30.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.8 percentage points.
Stran & Company's operating margin was 0.3% in Q2 2026, reflecting core business profitability. This is down 0.9 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.8 percentage points.
Stran & Company's net profit margin was 0.9% in Q2 2026, showing the share of revenue converted to profit. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.5 percentage points.
Stran & Company's ROE was 1.0% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.0 percentage points from the same quarter a year earlier. Against the prior quarter it is down 1.4 percentage points.
Capital Allocation
Stran & Company invested $17K in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 78.2% from the same quarter a year earlier. Against the prior quarter it is up 325.0%.
Not reported for Q2 2026.
Not reported for Q2 2026.
SWAGW Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.4M+2.4% | $31.2M+8.9% | $28.9M+7.2% | $26.0M+29.0% | $32.6M+95.2% | $28.7M+52.4% | $27.0M+17.7% | $20.1M+2.4% |
| Cost of Revenue | $23.3M+2.8% | $21.6M+6.9% | $20.1M+10.6% | $18.9M+33.2% | $22.7M+102.3% | $20.2M+53.0% | $18.2M+20.2% | $14.2M+6.9% |
| Gross Profit | $10.0M+1.6% | $9.6M+13.7% | $8.8M+0.3% | $7.1M+18.8% | $9.9M+80.5% | $8.5M+51.1% | $8.8M+12.6% | $6.0M-7.0% |
| SG&A Expenses | $9.9M+4.9% | $9.0M-0.2% | $8.8M-9.0% | $8.9M+8.8% | $9.5M+44.1% | $9.0M+43.6% | $9.7M+32.3% | $8.1M+41.9% |
| Operating Income | $86K-78.2% | $645K+220.6% | -$35K+96.3% | -$1.8M+18.4% | $395K+135.6% | -$535K+19.5% | -$937K-163.2% | -$2.2M-427.4% |
| EBITDA | $376K-41.6% | $940K+457.4% | $263K+138.5% | -$1.5M+23.5% | $644K+171.8% | -$263K+50.9% | -$684K-295.4% | -$2.0M-330.0% |
| Income Tax | $19K-83.3% | $46K+221.1% | $116K | -$72K-7100.0% | $114K+3700.0% | -$38K | N/A | -$1K+99.3% |
| Net Income | $309K-51.9% | $744K+289.3% | $243K+141.5% | -$1.2M+39.2% | $643K+162.7% | -$393K+20.0% | -$586K-142.1% | -$2.0M-261.1% |
| EPS (Basic) | $0.02-33.3% | $0.04+300.0% | $0.01+133.3% | -$0.07+36.4% | $0.03+150.0% | -$0.02+33.3% | -$0.03-200.0% | -$0.11-257.1% |
| EPS (Diluted) | $0.02-33.3% | $0.04+300.0% | $0.01+133.3% | -$0.07+36.4% | $0.03+150.0% | -$0.02+33.3% | -$0.03-200.0% | -$0.11 |
| Diluted Shares (Avg) | 19M+0.9% | 19M+0.3% | N/A | 18M-1.1% | 19M0.0% | 19M+0.2% | N/A | 19M |
Not reported in any period shown, so not listed: R&D Expenses, Interest Expense.
SWAGW Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $56.9M-7.1% | $53.2M+1.9% | $49.3M-10.5% | $50.3M+3.0% | $61.2M+31.4% | $52.2M+8.8% | $55.1M+12.5% | $48.8M-20.4% |
| Current Assets | $47.0M-6.2% | $42.9M+1.7% | $38.6M-15.0% | $39.3M+1.8% | $50.1M+22.7% | $42.2M+0.4% | $45.5M+5.7% | $38.6M-19.9% |
| Cash & Equivalents | $7.4M-43.3% | $7.6M+80.5% | $6.8M-27.8% | $6.7M-33.3% | $13.1M+10.1% | $4.2M-55.3% | $9.4M+16.1% | $10.0M+7.2% |
| Short-Term Investments | $5.2M+3.9% | $5.1M-35.6% | $4.9M-45.0% | $5.1M-27.1% | $5.0M-48.0% | $7.9M-25.9% | $8.9M-14.8% | $6.9M-32.4% |
| Inventory | $10.8M+60.0% | $8.6M+11.7% | $7.6M+41.4% | $7.7M+62.3% | $6.7M+69.5% | $7.7M+81.0% | $5.4M+12.7% | $4.8M-30.9% |
| Accounts Receivable | $20.3M-8.1% | $17.4M-4.7% | $17.3M-4.6% | $16.6M+20.9% | $22.1M+83.6% | $18.3M+28.8% | $18.1M+11.5% | $13.7M-16.8% |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $2.3M0.0% | $2.3M0.0% | $2.3M0.0% | $2.3M-8.7% | $2.3M | $2.3M | $2.3M | $2.5M |
| Total Liabilities | $25.4M-13.6% | $21.8M+4.1% | $18.8M-19.8% | $20.1M+21.5% | $29.4M+138.7% | $20.9M+64.5% | $23.5M+75.6% | $16.5M-35.4% |
| Current Liabilities | $23.9M-10.0% | $19.6M+1.7% | $16.5M-25.6% | $17.3M+16.1% | $26.6M+149.8% | $19.2M+80.8% | $22.2M+98.4% | $14.9M-11.9% |
| Non-Current Liabilities | $1.4M-48.1% | $2.2M+33.0% | $2.3M+78.7% | $2.7M+72.5% | $2.8M+67.1% | $1.7M-19.8% | $1.3M-40.4% | $1.6M-72.3% |
| Total Equity | $31.5M-1.1% | $31.4M+0.4% | $30.5M-3.6% | $30.2M-6.5% | $31.8M-7.2% | $31.3M-11.3% | $31.6M-11.2% | $32.3M-9.6% |
| Retained Earnings | -$6.4M+0.9% | -$6.7M+5.5% | -$7.5M-11.1% | -$7.7M-25.6% | -$6.5M-57.6% | -$7.1M-131.0% | -$6.7M-159.1% | -$6.2M-2716.3% |
Not reported in any period shown, so not listed: Long-Term Debt.
SWAGW Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $375K-94.2% | $1.2M+120.0% | $161K-87.9% | -$5.4M-95.9% | $6.4M+204.8% | -$5.9M-386.1% | $1.3M+240.0% | -$2.7M+48.7% |
| Depreciation & Amortization | $290K+16.5% | $295K+8.5% | $299K+19.6% | $288K+24.7% | $249K+18.0% | $272K+110.9% | $250K+36.6% | $231K+26.9% |
| Stock-Based Compensation | $35K+12.9% | $159K+1666.7% | N/A | $25K+733.3% | $31K+55.0% | $9K-94.0% | N/A | $3K-50.0% |
| Capital Expenditures | $17K-78.2% | $4K-96.8% | $123K+32.3% | $498K+245.8% | $78K-55.7% | $124K-34.0% | $93K-54.4% | $144K-33.3% |
| Free Cash Flow | $358K-94.4% | $1.2M+119.6% | $38K-96.9% | -$5.9M-103.4% | $6.3M+228.5% | -$6.0M-421.5% | $1.2M+207.3% | -$2.9M+48.1% |
| Investing Cash Flow | -$89K-103.1% | -$250K-130.9% | $102K+105.0% | -$572K-151.6% | $2.9M+195.5% | $809K+241.4% | -$2.0M-574.0% | $1.1M+395.5% |
| Financing Cash Flow | -$526K-8.0% | -$35K+12.5% | -$207K-644.7% | -$433K-110.2% | -$487K+30.4% | -$40K+33.3% | $38K+180.9% | -$206K+21.7% |
| Share Buybacks | N/A | N/A | $0 | $408K | N/A | N/A | N/A | N/A |
Not reported in any period shown, so not listed: Dividends Paid.
SWAGW Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.0%-0.3pp | 30.9%+1.3pp | 30.4%-2.1pp | 27.2%-2.3pp | 30.3%-2.5pp | 29.6%-0.3pp | 32.5%-1.5pp | 29.5%-3.0pp |
| Operating Margin | 0.3%-0.9pp | 2.1%+3.9pp | -0.1%+3.4pp | -6.9%+4.0pp | 1.2%+7.8pp | -1.9%+1.7pp | -3.5%-1.9pp | -10.8%-14.2pp |
| Net Margin | 0.9%-1.0pp | 2.4%+3.8pp | 0.8%+3.0pp | -4.8%+5.3pp | 2.0%+8.1pp | -1.4%+1.2pp | -2.2%-1.1pp | -10.1%-16.5pp |
| Return on Equity | 1.0%-1.0pp | 2.4%+3.6pp | 0.8%+2.7pp | -4.1%+2.2pp | 2.0%+5.0pp | -1.3%+0.1pp | -1.9%-1.2pp | -6.3%-9.8pp |
| Return on Assets | 0.5%-0.5pp | 1.4%+2.1pp | 0.5%+1.6pp | -2.5%+1.7pp | 1.1%+3.3pp | -0.8%+0.3pp | -1.1%-0.6pp | -4.2%-6.2pp |
| Current Ratio | 1.96+0.1x | 2.200.0x | 2.34+0.3x | 2.27-0.3x | 1.88-2.0x | 2.20-1.8x | 2.05-1.8x | 2.59-0.3x |
| Debt-to-Equity | 0.81-0.1x | 0.690.0x | 0.62-0.1x | 0.66+0.2x | 0.92+0.6x | 0.67+0.3x | 0.74+0.4x | 0.51-0.2x |
| Asset Turnover | 0.59+0.1x | 0.590.0x | 0.59+0.1x | 0.52+0.1x | 0.53+0.2x | 0.55+0.2x | 0.490.0x | 0.41+0.1x |
| FCF Margin | 1.1%-18.4pp | 3.8%+24.7pp | 0.1%-4.5pp | -22.6%-8.3pp | 19.5%+7.9pp | -21.0%-30.9pp | 4.6%+9.6pp | -14.3%+13.9pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Stran & Company SWAGW | FY2025 | $116.2M | -$747K | -0.6% | N/A | 44/100 |
| Stran & Company Inc SWAG | FY2025 | $116.2M | -$747K | -0.6% | $32.2M | 44/100 |
| Hainan Manaslu Acquisition Corp ABLVW | FY2025 | $105.2M | $820K | 0.8% | N/A | 41/100 |
| Fluent, Inc. FLNT | FY2025 | $208.8M | -$27.2M | -13.0% | $98.6M | 28/100 |
| CTRL Group Ltd MCTR | FY2025 | $3.9M | -$3.4M | -88.1% | $14.9M | 29/100 |
Where Stran & Company Ranks
Frequently Asked Questions
What is Stran & Company's annual revenue?
Stran & Company (SWAGW) reported $116.2M in total revenue for fiscal year 2025. This represents a 40.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Stran & Company's revenue growing?
Stran & Company (SWAGW) revenue grew by 40.6% year-over-year, from $82.7M to $116.2M in fiscal year 2025.
Is Stran & Company profitable?
No, Stran & Company (SWAGW) reported a net income of -$747K in fiscal year 2025, with a net profit margin of -0.6%.
What is Stran & Company's EBITDA?
Stran & Company (SWAGW) had EBITDA of -$850K in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is Stran & Company's gross margin?
Stran & Company (SWAGW) had a gross margin of 29.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Stran & Company's operating margin?
Stran & Company (SWAGW) had an operating margin of -1.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Stran & Company's net profit margin?
Stran & Company (SWAGW) had a net profit margin of -0.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Stran & Company's return on equity (ROE)?
Stran & Company (SWAGW) has a return on equity of -2.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Stran & Company's free cash flow?
Stran & Company (SWAGW) recorded an outflow of $5.5M in free cash flow during fiscal year 2025. This represents a -354.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Stran & Company's operating cash flow?
Stran & Company (SWAGW) recorded an outflow of $4.7M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Stran & Company's total assets?
Stran & Company (SWAGW) had $49.3M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Stran & Company's capital expenditures?
Stran & Company (SWAGW) invested $823K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is Stran & Company's current ratio?
Stran & Company (SWAGW) had a current ratio of 2.34 as of fiscal year 2025, which is generally considered healthy.
What is Stran & Company's debt-to-equity ratio?
Stran & Company (SWAGW) had a debt-to-equity ratio of 0.62 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Stran & Company's return on assets (ROA)?
Stran & Company (SWAGW) had a return on assets of -1.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Stran & Company's Piotroski F-Score?
Stran & Company (SWAGW) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Stran & Company's earnings high quality?
Stran & Company (SWAGW) reported a net loss of $747K while operations used $4.7M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Stran & Company?
Stran & Company (SWAGW) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is a 0-100 composite of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.